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ABSTRACT
The vast majority of infections involving female pelvic structures arise from organisms that are
members of the normal flora. In addition, exogenous organisms that invade through the lower
genital tract must interact with organisms that are part of the host’s flora. In contrast to the concept
that the normal flora is entirely innocuous, recent research has begun to identify what appear to be
virulence attributes among these ordinarily low-virulence organisms. Most of our understanding of
virulence has been derived from highly virulent organisms, ofwhich Neisseria gonorrhoeae provides
an example ofrelevance to the female genital tract. A review ofthe virulence factors ofthe gonococ-
cus is presented to serve as an example of the variety of virulence properties associated with
pathogenic bacteria. Molecular biology has begun to clarify one of the important paradigms of
pathogenic bacteriology--that bacteria change their expression ofvirulence properties in response to
their location within a host or to the stage of infection. Thus, infection involves not only the
possession of virulence factors, but also the carefully controlled use of those factors. Virulence is
often controlled by the coordinate expression ofmany virulence-associated genes in response to one
environmental signal. With regard to low-virulence organisms present in the female lower genital
tract, we are beginning to identify some of their virulence attributes. Examples from the work ofour
laboratory include the hemolysin of Gardnerella vaginalis and an immunosuppressive mycotoxin
produced by Candida albicans. Demonstrating the coordinate expression (or other control mecha-
nisms) of virulence factors in these sometimes innocuous and sometimes inimical organisms repre-
sents the next frontier in the study ofnormal vaginal microbiology. (C) 1994 Wiley-Liss, Inc.
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virtual avalanche of data providing an under-
standing of virulence at cellular and molecular
levels has occurred in the last decade, largely as a
result of the availability of laboratory methods that
permit the investigation of gene expression and
regulation. However, the majority of basic work
done on virulence has focused, not surprisingly, on
the seemingly most dangerous microorganisms. For
example, the organism responsible for plague
(Yersinia pestis) and its near kin (Y. enterocolitica)
have been studied extensively, resulting in the rec-
ognition of more than 2 dozen gene products that
either function directly as virulence factors or are
involved in the regulation of virulence. Likewise,
organisms that generally appear in association with
specific disease entities (anthrax, tuberculosis, toxic
shock syndrome, salmonellosis) have also been stud-
ied to the level of molecular detail. However, many
opportunistic organisms, sometimes described as
low-virulence organisms, have received less scru-
tiny.
Despite our burgeoning understanding of viru-
lence attributes and the genes responsible for them,
the basic conceptual framework for describing the
development of infectious diseases on the level of
the entire host can still be broadly defined in terms
of the virulence and number of microorganisms
counterpoised by the defense mechanisms of the
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host. What has come about in the half century since
Theobald Smith
2 formulated the concept of infec-
tious disease in these terms is the identification of
the actual molecular components of both virulence
and host defense as well as a recognition of the
dynamic interaction of these factors.
Historically, heroic efforts were required to con-
vince skeptics that living things too small to be seen
with the naked eye could cause devastating diseases
affecting a host many billions times larger than the
microorganism. In the golden age of microbiology,
such pioneers as Koch and Pasteur identified differ-
ent species of microorganisms and associated each
one with certain typical infectious processes. The
differences among species were consistent as were
the diseases the organisms caused, giving rise to the
concept, "one microorganismone disease." There
was little suspicion at that time that a single species
of microbe may behave differently or in a more
virulent manner, depending on its environment.
Today, we recognize that microorganisms have the
ability to regulate their virulence properties in re-
sponse to their surroundings. Therefore, it is not
only necessary to identify the microbial factors that
confer virulence on the organism, but equally im-
portant to discover the environmental signals regu-
lating the production of these factors. With regard
to those organisms displaying little intrinsic viru-
lence, the state-of-the-art still lies in identifying
virulence attributes, while the task of identifying
the genetic regulatory mechanisms remains to be
investigated. In this article, some examples are pro-
vided to illustrate the developing science surround-
ing the virulence of microorganisms found in the
female lower genital tract, organisms typically
deemed to exhibit minimal virulence.
VIRULENCE AND HOST DEFENSE
The dynamic relationship between host defense and
microbial virulence in infectious diseases indicates
that it is insufficient to view virulence attributes as
a collection of substances that do some harm to host
cells. Microorganisms may enhance their virulence
by producing factors that act against host defense
factors or in response to them. Some instructive
examples may be found with Neisseria gonorrhoeae,
which possesses virulence factors that specifically
circumvent host defenses.
Gonococcal Pilin
As with any invasive organism, the host responds to
infection by the production ofan antibody response.
Each bacterial pathogen may present a very large
number of antigenic epitopes to which antibody
may be produced. When the immune response
blocks the function of a key virulence factor, the
infectivity of the microorganism should be severely
limited. However, antigenic variation can, in ef-
fect, make such a virulence factor a moving target,
leaving the immune system prepared to respond to
an antigenic display that is pass6.
3 The gonococcal
pilus is considered to be one of the most significant
virulence factors because it represents the adhesive
surface component allowing attachment of the mi-
croorganism to columnar epithelial cells. This rep-
resents the initial step in the natural history of
gonococcal disease. The gonococcus is able to un-
dergo phase variation (at low frequency) whereby
the organism becomes pilus negative, a condition
resulting in loss of infectivity. Antigenic variation
(which occurs with relatively high frequency) re-
sults in alterations of the primary structure of the
pilin molecule, the approximately 18 KD subunit
forming the pilus assembly. Both antigenic and
phase variations occur as a result of rearrangement
of the genetic material involved in pilin synthesis,
expeession, and transport to the microorganism’s
exterior. Two mechanisms are responsible for anti-
genic and phase variations: intragenic recombina-
tion within the chromosome of the gonococcus or
intergenic recombination with transforming DNA
from another gonococcal cell.
Genetic studies
4 of pilus production have been
reviewed recently, and an abbreviated summary of
the pilus gene rearrangements is noted here. The
pilus gene is composed of expressed (pilE) and
silent (pilS) loci. The silent region lacks a promoter
and is composed of numerous copies of the pilin
coding sequence, but these are truncated to varying
degrees. Thus, while they do not encode the pilin
produced by the gonococcus, they provide a source
of genetic material from which the organism can
generate antigenically diverse pilin proteins. The
expressed locus produces a prepilin which must be
post-translationally modified to replace an N-ter-
minal export signal sequence with N-methylation
of the initial phenylalanine of the pilin. Although
the pilin molecule contains relatively conserved re-
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gions at the N-terminus of the molecule, there are 6
"minicassettes" located from the middle to the C-ter-
minus of the pilin molecule that typically undergo
recombination with material from the pilS locus,
resulting in pili displaying new antigenic epitopes.
Although reassortment of the variable regions of
the pilin gene results in antigenic variation, phase
variation occurs when recombination leads to a pi-
lin that is post-transcriptionally modified at amino-
acid number 40 instead of the normal cleavage of
the signal peptide at position 1. This type of pilin
cannot be assembled into fimbrial structures and is
either secreted in soluble form or accumulates in
the periplasmic space as very long pilin molecules.
Thus, while the gonococcal pili represent a vir-
ulence attribute, pilin antigenic variability repre-
sents a further enhancement of their virulence by
frustrating the immune response.
IgAl Protease
Proteases of various kinds with a myriad of speci-
ficitie have been implicated as virulence factors
among microorganisms. Simultaneously, it must
be noted that the host also employs proteolytic en-
zymes as part of its defense against microbial patho-
gens.
One class of bacterial proteases which has proved
especially intriguing for investigators are proteases
that use human IgA1 as a substrate, IgA proteases
are usually associated with microorganisms that in-
vade the host from mucosal sites. These include the
gonococcus, meningococcus, Streptococcus pneumo-
niae, S. sanguis, and Hemophilus influenzae. The
enzyme in the gonococcus is produced as a large
molecule which is cleaved to produce the protease
and subunits that provide for secretion through the
gonococcal membrane to the extracellular environ-
ment.
6 The enzyme cleaves the antibody molecule
in the vicinity of the hinge region, releasing the
Fab fragment, an event sometimes whimsically re-
ferred to as "fabulation." Intuition would dictate
that such a system functions as the gonococcal an-
swer to secretory immunity, but we do not yet have
definitive proof of the role of IgA1 protease as a
virulence attribute. Much remains to be learned
about the concentration and specificity of antibody
that comes in contact with mucosal pathogens and
how secretory antibody may adversely affect the
gonococcus. Likewise, much remains to be learned
about the in vivo concentration and efficacy of the
gonococcal protease and whether it actually renders
IgA ineffectual at the site of infection.
Gonooal Iron Acquisition
Iron has long been recognized as having a role in
microbial virulence. Although it is a critical nutri-
ent for all organisms, a considerable number of
older studies indicated
7 that microorganisms in-
jected into experimental animals in the presence of
blood or heme produced infections more aggressive
than those produced by a similar inoculum injected
in the absence of excess iron. Many bacteria obtain
iron by synthesizing chelators (siderophores) which
have the ability to acquire iron from the host. How-
ever, N. gonorrhoeae is not a siderophore producer
and therefore must use an alternative system for
iron acquisition. The gonococcus produces specific
receptors for transferrin and lactoferrin, the iron
binding/transporting proteins of the host. The or-
ganism does not conduct a robbery of the iron, but
more like a hijacking, obtains iron by appropriat-
ing the vehicle along with its load of iron. Recent
evidence indicates that the transferrin receptor sys-
tem is a multicomponent system containing 2 pro-
teins and showing some antigenic variability.
9 Al-
though there is immunologic cross-reactivity
between transferrin ligands found in gonococci,
meningococci, and H. influenzae, the bacterial
product does not cross-react with human transfer-
tin receptors.
It should be emphasized that the operation of
this iron-acquisition system is a regulated one. In
the presence of iron excess, special iron-acquiring
systems are not needed. Therefore, iron serves as a
regulatory signal for a group of bacterial products
collectively referred to as FeRPs (iron-repressible
proteins). Other regulatory systems have been noted
as well in the gonococcus. In addition to the pilE
locus, the operon contains the pilA and pilB loci
which appear to have regulatory functions over
outer-membrane proteins which, in turn, have an
influence on virulence, cell invasion, and serum
resistance. These loci appear to be responsive to
environmental signals and have homology with reg-
ulatory elements of other bacterial systems.
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VIRULENCE PARADIGM
The reason that microorganisms control expression
of virulence factors is probably more complex than
simply a matter of conserving metabolic energy
when some factor is not needed. Many pathogenic
organisms have exceedingly complicated lifestyles,
such as those involved in zoonotic diseases. An
organism like the plague bacillus may have to adapt
to such diverse environments as a warm- or cold-
blooded host and different species of mammals.
Only by delicate regulation of growth and viru-
lence factors can the organism be successful.
At first glance, the life of the gonococcus seems
simple in contrast to an organism like the plague
bacillus. However, while its normal environment
is within the human host, the gonococcus inhabits a
variety of locations in that host (cervix, rectum,
urethra, bloodstream, fallopian tubes, and other
sites) and each of these sites has a particular tissue
architecture, competing microbial flora, chemically
unique lumenal fluids, and different host defense
properties. The ability to adapt to these various
conditions appears to be inherent in the pathogen’s
ability to thrive in the host. The virulence factors
described above do not represent an exhaustive list
but portray some of the functions of the gonococcus
that illustrate the principles involved in the modern
understanding of virulence. Based on the example
of N. gonorrhoeae, the nature of microbial viru-
lence can be summarized in the following terms:
1. Pathogenicity may result from specific micro-
bial virulence factors or activities that a) cause
harm to host tissues or disrupt some physiologic
process or b) inactivate or otherwise subvert
host defenses.
2. Adherence to mucosal sites represents the first
step in pathogenesis and is attributed to molecu-
lar structures on the microbial surface which
bind to ligands on susceptible host tissues. In
the gonococcus, in addition to the pili which
serve as the major adhesins, there is evidence to
support the ability of other surface glycolipids
and Opa (opacity) proteins to bind to host cells
as well.
0,
3. Regulation of gene function in response to the
microenvironment is an essential aspect of viru-
lence. In addition to causing the induction of
virulence attribute, genetic regulation may si-
multaneously affect several genetic loci. Such
transcription of several different gene products
in response to a single stimulus, described as
global (coordinate) regulation, is becoming rec-
ognized as an important motif in virulence reg-
ulation. Microorganisms are able to utilize well-
characterized sensory and control systems to
induce the transcription of gene products that
allow the organism to persist in the host. Nu-
merous environmental signals have been identi-
fied in bacteria. In addition to iron, the gono-
coccus senses oxygen tension and nutrients in
regulating the expression of some of its genes.
4. Invasion can be loosely defined as the ability of
an organism to cross barriers in the host, result-
ing in the infectious process moving or spread-
ing from its primary site. This process may take
the form of microorganisms entering tissues ei-
ther by interstitial spread to cross barriers (such
as an epithelial surface) or it may represent the
entry of the microorganism into cells. The term
invasin has been applied to bacterial products
that are specifically responsible for the entrance
of microorganisms into tissues. Fallopian-tube
explant culture has shown that the gonococcus is
able to reach the basement membrane by enter-
ing a columnar epithelial cell at the apical sur-
face, traveling through the cell, and exiting by
exocytosis at the basal portion of the cell.
12
There is some evidence to indicate that the porin
protein (outer-membrane protein P I) may play
a role in coalescence with host membranes, ulti-
mately leading to internalization of the gonococ-
CHS.
12 Although the role of P I is not yet cer-
tain, for purposes of the present discussion, it is
useful to recognize that the gonococcus has some
factor that functions as an invasin, whether or
not the invasin is also a porin.
5. Intoxication, or the production of microbial
products that cause some identifiable damage to
host cells or interfere with cellular functions, is
better known for pathogens other than N. gon-
orrhoeae. Despite this, most investigators be-
lieve that the toxic properties of the gonococcal
lipooligosaccharide on the outer membrane of
the organism and possibly the peptidoglycan of
the cell wall contribute to some of the damage it
produces in vivo. The ciliostasis and histopa-
thology occurring in fallopian-tube explants ex-
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posed to the gonococcus are believed to be due to
lipooligosaccharide.
After this review of some of the aspects of the
gonococcus which account for its virulence, it is
appropriate to consider whether virulence factors
exist in microorganisms that are inconsistently
found in pathogenic relationship with the host.
PATHOGENICITY OF NORMAL
FLORA ORGANISMS
Little space will be devoted here to the concept,
developed elsewhere, that the indigenous microbial
flora of the vagina is a diverse collection of aerobic
and anaerobic organisms living in a dynamic rela-
tionship with the colonized epithelium. Although
colonization of the lower female genital tract is
generally benign, many microorganisms are in-
volved, from time to time, in symptomatic infec-
tions. Among the conditions for which the normal
cervicovaginal flora has relevance are the polymi-
crobial infections involving operative sites after sur-
gical procedures, postpartum endomyometritis, sal-
pingeal and ovarian infections that occur in tempo
with lower-tract gonococcal and/or chlamydial in-
fections, and the vaginal conditions of mucocutane-
ous candidiasis and bacterial vaginosis.
Because the primary emphasis of this article is on
the virulence of microorganisms, host defense will
receive little attention here. Certainly, in the case of
surgical infections, postpartum infections, and the
mixed upper-tract invasion characteristic of pelvic
inflammatory disease, a breach of the host defenses
is of paramount importance. These represent cases
in which significant numbers of normal flora or-
ganisms are precipitously transferred to an envi-
ronment that may be conducive to rapid prolifera-
tion. It is tempting to attribute the symptoms of
infection in these cases solely to the location of the
organisms and not to any virulence properties they
possess. This view is very likely a short-sighted
assessment of the pathogenesis of these infections,
although the research on virulence factors in these
organisms is limited. A recent review by Brook
14
noted the importance of synergy between aerobic
and anaerobic organisms coexisting at an infected
site. Synergy in this setting rnay be attributed to
various factors including the consumption of oxy-
gen by aerobic species or production of antiphago-
cytic factors by anaerobic species. For example,
succinate produced by some species of anaerobic
bacteria has been shown to have an adverse effect on
neutrophil chemotaxis.
15 Brookl4 also emphasized
the abscessogenic property of anaerobic bacteria
(Bacteroides, Porphyromonas, and Prevotella spp.)
which may add to the virulence of the organisms
through antiphagocytic activity. Finally, in view of
the virulence enhancement that comes from includ-
ing blood in bacterial inocula, the surgical site
would seem to be a prime location for bacteria to
undergo virulence induction. The possibility that
organisms associated with vaginal symptoms, i.e.,
Gardnerella, anaerobic flora, Candida, also possess
inducible virulence attributes should be considered.
Among vaginal organisms, C. albicans has perhaps
undergone the closest scrutiny in recent years be-
cause it is among the most important causes of
nosocomial infections and is a common cause of
mucocutaneous disease in acquired immunodefi-
ciency syndrome (AIDS) patients. In the gyneco-
logic context, the organism is of interest as a cause
of vaginal symptoms, although it is also appropri-
ately deemed to be a part of the host’s normal flora
and, in its role as natural flora, it would seem to be
a low-virulence organism. In the vagina, it displays
little more than microinvasiveness, but other viru-
lence characteristics such as attachment, interaction
with host defense factors, and toxigenicity exist.
Because the organism can flourish in the vagina
either as a commensal or as a cause of vaginal
symptoms or can disseminate to cause septicemia
with multiple organ infections, virulence regula-
tion in this organism is probably a necessity.
Attachment of Low-Virulence Organisms to
Host Tissues
Attachment ofthe organism to the epithelial surface
is a significant aspect of the life of a vaginal micro-
organism. Various studies of attachment have been
reported which have provided some information
about the mechanisms of fungal adherence, but
some caution is warranted in evaluating these stud-
ies. Some investigations employed buccal epithe-
lium as a surrogate for the vaginal epithelial cell.
Although Candida adheres to both cell types, it is
not clear whether the mechanism of adherence is
identical for both cell types. The ability of Candida
to enter a mycelial phase is an important consider-
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ation, and some evidence indicates that germinated
cells adhere better to vaginal epithelium than do
yeast cells.
16 We found that rats artificially inocu-
lated with yeast-phase organisms only became colo-
nized when they were well estrogenized and that,
when viewed by scanning electron microscopy, the
yeast inoculum had become uniformly mycelial.
17
Moreover, the electron micrographs suggested that
these mycelial organisms showed superficial inva-
sion of the epithelium, which one might view as an
extreme form of attachment.
Heterogeneity among vaginal epithelial cells fur-
ther complicates studies of microbial adhesion. In
addition to individual variation in tissue architec-
ture, vaginal epithelium undergoes different de-
grees of maturation at different times within a sin-
gle individual. In our laboratory, we have used
fluorescence microscopy to accurately quantitate
various strains of yeast attached to exfoliated vagi-
nal cells. By evaluating yeast adherence to vaginal
cells from several donors against several yeast
strains, we determined that patient-to-patient vari-
ation in epithelial-cell adhesiveness was greater than
interstrain variation in yeast adhesiveness (Larsen,
unpublished results, 1992). This result was antici-
pated since considerable variation in yeast adher-
ence to buccal cells was noted by Sandin and co-
workers.
18
Future studies will need to determine the precise
adhesive structures involved in yeast adherence to
vaginal cells at various stages of maturation and
whether different adhesins exist in yeast vs. myce-
lial forms of the organism. Although the manno-
proteins of the yeast are thought to represent the
major adhesins, 19’2 the ability of yeast to bind
fibrinogen
21 has led to the concept that Candida
may have ligand for fibronectin. Kalo et al.
22 sug-
gested that fibronectin on intermediate ceils of the
female genital tract was a good ligand for C. albi-
cans, but superficial cells had far less fibronectin
and were therefore less receptive to yeast adher-
ence. Vaginal epithelial maturation to the interme-
diate stage is characteristic of states of high circulat-
ing progesterone (as in pregnancy), so these
observations may have at least a theoretical clinical
correlation. Sawyer and colleagues
23 found that the
RGD (arg-gly-asp) domain binds to Candida and
opsonizes them for Kuppfer-cell phagocytosis and
may have an important role in hepatic trapping of
the organism. This property may have more rele-
vance to disseminated infection than to mucocuta-
neous colonization. More to the issue of mucocuta-
neous candidiasis is the work of Ollert and
coworkers,
24 who studied the inhibition of yeast
adherence to keratinocytes in the presence of vari-
ous inhibitors. While fibronectin provided some
competition for yeast-keratinocyte interaction, RGD
did not. Greater inhibition was achieved with sac-
charide inhibitors, most notably D-glucosamine.
These authors also found the acid proteinase inhib-
itor pepstatin A to be an effective inhibitor of ad-
herence in their assay system which they considered
to provide evidence that secreted protease also plays
a role in adhesion. The various observations on
yeast attachment are consistent with the presence of
major and minor adhesins that function in different
environments. Work has shown that a Candida re-
ceptor analog which binds C3b participates in an
integrin-like binding to RGD sequences and, in
addition to anticomplement activity, may be impor-
tant in fungal attachment to endothelial cells.
2s
Microbial attachment has been less studied for
other organisms of relevance in the lower female
genital tract. G. vaginalis, which is common among
asymptomatic women and seen in abundance in
individuals with bacterial vaginosis, is noted for its
adherence to epithelial cells. Heavily colonized ex-
foliated vaginal cells have been described as clue
cells, although the molecular mechanisms of adher-
ence have not been worked out. Boustouller et al.
26
attributed the responsibility of attachment to vagi-
nal epithelial cells to pili, whereas Scott and col-
leagues
27 considered an outer fibrillar matrix re-
sponsible for cytadhesion, with pili functioning as a
hemagglutinin.
It must be emphasized that, despite the impor-
tance of microbial adherence in disease processes,
attachment to tissue does not identify an organism
as a pathogen. Indeed, vaginal lactobacilli possess
adhesins which probably serve to promote their
stable colonization of the vaginal epithelium, possi-
bly with beneficial effect for the host.
28 Thus,
whether the microbial species is highly virulent or
only modestly virulent, its successful interaction
with the host tissue depends on adhesive factors.
Virulence Regulation
in Low-Virulence Organisms
An additional characteristic of virulence is the abil-
ity to genetically regulate virulence attributes. The
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genetics of C. albicans is beginning to receive con-
siderable research attention,
29 although studies on
regulation of virulence factors remain rudimen-
tary. It is clear that Candida can regulate some of its
virulence factors, although details of how and why
such regulation occurs are obscure. Furthermore,
the regulation of virulence is currently recognized
at the level of phenotype rather than at the level of
genetic control. It will be sufficient at this point to
mention a few of the systems that appear to undergo
regulation in Candida.
The most obvious type of regulation involves the
morphology of the organism. The ability of the
organism to germinate has long been associated
with its pathogenic function. This concept is based
on the fact that the usual form of the fungus in the
host is the mycelial phase. This form is considered
to be too cumbersome to be readily phagocytosed
and is believed to possess microinvasive properties.
This may be reflected in the ability of hyphal or-
ganisms to bind fibrinogen, laminin, and comple-
ment products, a property not shared by the yeast
f’orm.
3-32 It is well known that placing yeast cells
of C. albicans in serum causes their prompt germi-
nation. In addition, the recent report oDeBernar-
dis and coworkers
33 suggests that the contact of
yeast with epithelium triggers a conversion to myce-
lial growth including the expression of new surface
mannoprotein epitopes. Thus, the organism dis-
plays the ability to sense its environment and re-
spond to it in a manner that theoretically enhances
its virulence.
The discovery of a complement receptor analog
on C. albicans and C. stellatoidea by Heidenreich
and Dierich
34 revealed an important potential vir-
ulence attribute of the organism. It is postulated
that this receptor analog serves as an antiphagocytic
factor by binding complement split products which
normally bind to neutrophil receptors.
3s It is nota-
ble that these investigators found this factor associ-
ated with hyphal forms of the organism
35 and dem-
onstrated that it was induced by elevated glucose
concentrations.
36 To describe these events as a glo-
bally regulated virulence system goes beyond cur-
rent knowledge and will require confirming basic
genetic investigation. Even so, this system appears
to function as a regulated virulence system.
C. albicans also appears to spontaneously un-
dergo a phenotypic change in colonial morphology
that has been described as "high-frequency switch-
ing.
’’37 The spontaneous changes that occur in col-
ony type are reminiscent of the spontaneous changes
and gonococcal antigen presentation described ear-
lier. Switching probably involves genetic mecha-
nisms different from those seen in the gonococcus,
but a similar purpose of evading the immune sys-
tem may accrue to the switching Candida.
38
One important characteristic of global regula-
tion is a sensor mechanism or a chemoreceptor that
identifies the changing environment for the micro-
organism. The effects of various nutrients in rela-
tion to adherence phenomena were reviewed by
Calderone and Braun
19 and are not repeated here.
An alternative sensory mechanism that may have
particular significance for Candida in the mamma-
lian host is estrogen-binding activity.
39 Transcrip-
tional regulating activity similar to that of classic
mammalian estrogen receptors has not been ob-
served in yeast, but there are discernible biological
effects of estrogen on C. albicans. In our labora-
tory, we have noted that micromolar estradiol in-
creases biomass production in vitro and enhances
the production of toxin,
g
Toxigenicity of Low-Virulence Organisms
Clearly, the organisms that normally associate with
the host as normal commensal flora have been given
little attention as toxin producers. But the produc-
tion of toxic substances with subtle effects on the
host physiology or immunity could play a role in
the virulence of these organisms. As noted for the
gonococcus, the endotoxin it produces may not serve
as its primary virulence factor, but is probably
responsible for some of its effects in the upper
genital tract or in disseminated disease.
G. vaginalis produces a hemolysin which is one
of its key identifying characteristics. Research from
our laboratory
41-43 and that of other investiga-
tors44’45 have characterized the hemolytic toxin
from this organism. There is ample precedent
among other bacteria to indicate that hemolysins
contribute to microbial virulence. Despite the fact
that Gardnerella alone is not usually involved in
infections, its hemolysin may contribute to this or-
ganism’s participation in bacterial vaginosis.
We found that the hemolysin is produced in
soluble form in the presence of serum or other
releasing factors, but in serum-free medium the
hemolysin remains bound to the bacterial cell.
4
Biochemical evidence indicates that this is a protein
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toxin which may be stabilized by associated lipid
42
and its native form is probably an aggregate of
60-65 KD monomers.
4 Although this toxin lyses
human erythrocytes, its action against polymorpho-
nuclear neutrophils may be more clinically rele-
vant.
43
The paucity of leukocytes in cases of bacterial
vaginosis is well known. We found that as few as 2
hemolytic units/ml of G. vagina& hemolysin was
able to arrest the chemotaxis of human neutro-
phils.
43 In anaerobic culture in peptone-yeast ex-
tract-glucose medium with serum, the organism
typically produced several hundred hemolytic units/
ml. The microbial ecology of bacterial vaginosis is
undeniably complex, and no single bacterium or
bacterial factor is responsible for the clinical pic-
ture. However, the observed biological activities of
the G. vaginalis hemolysin suggest its participation
in this condition.
Another organism that is not usually considered
to be toxigenic is C. albicans. As mentioned above,
C. albicans interacts with the host in some very
complex ways, but, despite the many investigations
on this orgariism, few studies consider the possibil-
ity of"exotoxin production. Based on sporadic claims
in the literature that Candida has immunosuppres-
sive properties, we began looking for an immuno-
suppressive mycotoxin. Some filamentous fungi
produce epipolythiodioxopiperazines that have im-
munosuppressive and antiphagocytic activity. We
developed a chromatographic procedure for the
best-known compound of this class of toxins and
determined that gliotoxin was present in the spent
culture supernatants of C. albicans.
46 We verified
the structure of the compound with mass spectros-
copy.
go Although the compound exerts various ad-
verse effects on neutrophil function including an
inhibition of directed migration (Shah and Larsen,
unpublished observations), it also has some inter-
esting stimulatory functions on isolated neutrophils.
Gliotoxin may cause degranulation and premature
release of lactoferrin from neutrophils and enhance
respiratory burst activity at very low concentra-
tions. The potential for these actions to influence
the development of mucocutaneous disease is clear,
but additional work is needed to define the role of
this immunomodulating toxin. One clear aspect of
gliotoxin production is that estradiol provides a
stimulus for toxin production,a As previously em-
phasized, this finding suggests that toxin produc-
tion, along with various other virulence attributes
in C. albicans, may be globally regulated.
CONCLUSIONS
Contemporary investigation of the pathogenic
mechanisms of infectious agents has revealed a
broad range of virulence attributes that damage
host cells or interfere with host functions. More-
over, these virulence attributes are often globally
regulated in response to environmental signals. Lit-
tle attention has been given to low-virulence organ-
isms associated with the host as part of the normal
flora. In this article, N. gonorrhoeae, was selected to
illustrate virulence characteristics that include 1)
interaction with host defenses, 2) adhesion to host
tissues, 3) regulation of virulence attributes, and 4)
elaboration of toxins. Evidence is presented to show
that similar virulence properties are associated with
the microbial inhabitants of the female lower geni-
tal tract. Far from being irrelevant to low-viru-
lence organisms, the study of virulence factors is a
fruitful area of investigation and one that may pos-
itively influence the health of women.
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